Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study.
Letarouilly JG, Pham T, Pierache A, Acquacalda É, Banneville B, Barbarot S, Baudart P, Bauer É, Claudepierre P, Constantin A, Dernis E, Felten R, Gaudin P, Girard C, Gombert B, Goupille P, Guennoc X, Henry-Desailly I, Jullien D, Karimova E, Lanot S, Le Dantec L, Pascart T, Plastaras L, Sultan N, Truchet X, Varin S, Wendling D, Gaboriau L, Staumont-Sallé D, Peyrin-Biroulet L, Flipo RM. Letarouilly JG, et al. Among authors: barbarot s. Rheumatology (Oxford). 2022 Jul 6;61(7):2848-2855. doi: 10.1093/rheumatology/keab819. Rheumatology (Oxford). 2022. PMID: 34730790
Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D; French Society of Dermatology and Club Rheumatisms and Inflammation. Faivre C, et al. Among authors: barbarot s. J Am Acad Dermatol. 2016 Jun;74(6):1153-9. doi: 10.1016/j.jaad.2016.01.018. Epub 2016 Mar 8. J Am Acad Dermatol. 2016. PMID: 26965410
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort.
Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Lacour JP, Schmutz JL, Bravard P, Mahé E, Beneton N, Misery L, Delaporte E, Modiano P, Barbarot S, Regnier E, Jullien D, Richard MA, Joly P, Tubach F, Chosidow O. Sbidian E, et al. Among authors: barbarot s. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2046-2054. doi: 10.1111/jdv.14406. Epub 2017 Jul 16. J Eur Acad Dermatol Venereol. 2017. PMID: 28609574 Free article.
Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis.
Phan C, Beauchet A, Burztejn AC, Severino-Freire M, Barbarot S, Girard C, Lasek A, Reguiai Z, Hadj-Rabia S, Abasq C, Brenaut E, Droitcourt C, Perrussel M, Mallet S, Phan A, Lacour JP, Khemis A, Bourrat E, Chaby G, Deborde R, Plantin P, Maruani A, Piram M, Maccari F, Fougerousse AC, Kupfer-Bessaguet I, Balguérie X, Barthelemy H, Martin L, Quiles-Tsimaratos N, Mery-Brossard L, Pallure V, Lons-Danic D, Bouilly-Auvray D, Beylot-Barry M, Puzenat E, Aubin F, Mahé E; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique; Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie. Phan C, et al. Among authors: barbarot s. J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1984-1992. doi: 10.1111/jdv.15579. Epub 2019 Apr 15. J Eur Acad Dermatol Venereol. 2019. PMID: 30883928
Evaluation of Children with Psoriasis from the BiPe Cohort: Are Patients Using Biotherapies in Real Life Eligible for Phase III Clinical Studies?
Phan C, Beauchet A, Burztejn AC, Severino-Freire M, Mazereeuw-Hautier J, Barbarot S, Girard C, Lasek A, Reguiai Z, Abasq C, Sassolas B, Droitcourt C, Perrussel M, Hadj-Rabia S, Mallet S, Phan A, Lacour JP, Bourrat E, Aubin F, Mahé E; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, and the Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie. Phan C, et al. Among authors: barbarot s. Paediatr Drugs. 2019 Jun;21(3):169-175. doi: 10.1007/s40272-019-00335-9. Paediatr Drugs. 2019. PMID: 31155692 Clinical Trial.
Switching biologics in children with psoriasis: Results from the BiPe cohort.
Phan C, Beauchet A, Reguiai Z, Severino-Freire M, Mazereeuw-Hautier J, Bursztejn AC, Barbarot S, Hadj-Rabia S, Girard C, Phan A, Lacour JP, Lasek A, Abasq C, Brenaut E, Perrussel M, Droitcourt C, Mallet S, Piram M, Fougerousse AC, Barthélémy H, Balguérie X, Mahé E; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, the Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie. Phan C, et al. Among authors: barbarot s. Pediatr Dermatol. 2022 Jan;39(1):35-41. doi: 10.1111/pde.14845. Epub 2021 Dec 9. Pediatr Dermatol. 2022. PMID: 34888920
Psoriasis and obesity in French children: a case-control, multicentre study.
Mahé E, Beauchet A, Bodemer C, Phan A, Bursztejn AC, Boralevi F, Souillet AL, Chiaverini C, Bourrat E, Miquel J, Vabres P, Barbarot S, Bessis D, Eschard C, Hadj-Rabia S; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Mahé E, et al. Among authors: barbarot s. Br J Dermatol. 2015 Jun;172(6):1593-1600. doi: 10.1111/bjd.13507. Epub 2015 Mar 22. Br J Dermatol. 2015. PMID: 25363889
[Impact of sex and age on the clinical and epidemiological aspects of childhood psoriasis: Data from a French cross-sectional multicentre study].
Bonigen J, Phan A, Hadj-Rabia S, Boralévi F, Bursztejn AC, Bodemer C, Ferneiny M, Souillet AL, Chiavérini C, Bourrat E, Miquel J, Vabres P, Barbarot S, Bessis D, Eschard C, Mazereeuw-Hautier J, Piram M, Plantin P, Abasq C, Lasek-Duriez A, Maruani A, Beauchet A, Mahé E; Groupe de recherche de la Société française de dermatologie pédiatrique. Bonigen J, et al. Among authors: barbarot s. Ann Dermatol Venereol. 2016 May;143(5):354-63. doi: 10.1016/j.annder.2016.02.006. Epub 2016 Mar 8. Ann Dermatol Venereol. 2016. PMID: 26969479 French.
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
Faiz S, Giovannelli J, Podevin C, Jachiet M, Bouaziz JD, Reguiai Z, Nosbaum A, Lasek A, Ferrier le Bouedec MC, Du Thanh A, Raison-Peyron N, Tetart F, Duval-Modeste AB, Misery L, Aubin F, Dompmartin A, Morice C, Droitcourt C, Soria A, Arnault JP, Delaunay J, Mahé E, Richard MA, Schoeffler A, Lacour JP, Begon E, Walter-Lepage A, Dillies AS, Rappelle-Duruy S, Barete S, Bellon N, Bénéton N, Valois A, Barbarot S, Sénéchal J, Staumont-Sallé D; Groupe de Recherche sur l'Eczéma aTopique (GREAT), France. Faiz S, et al. Among authors: barbarot s. J Am Acad Dermatol. 2019 Jul;81(1):143-151. doi: 10.1016/j.jaad.2019.02.053. Epub 2019 Feb 27. J Am Acad Dermatol. 2019. PMID: 30825533
314 results